Emergent BioSolutions Inc.
Ticker: 1367644
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q3 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 156.10-32.5% | 231.10+64.0% | 140.90-36.6% | 222.20-24.4% | 293.80+15.4% | 254.70-15.2% | 300.40+11.1% | 270.50 |
| Total Income | 156.10-32.5% | 231.10+64.0% | 140.90-36.6% | 222.20-24.4% | 293.80+15.4% | 254.70-15.2% | 300.40+11.1% | 270.50 |
| EXPENSES | ||||||||
| Expenditure | 145.60-5.8% | 154.60+11.0% | 139.30-19.2% | 172.30-24.9% | 229.30-50.0% | 458.20+75.8% | 260.60-49.2% | 512.60 |
| Tax | 6.60+3.1% | 6.40+233.3% | -4.80-119.4% | 24.70-10.5% | 27.60+107.5% | 13.30+329.0% | 3.10+224.0% | -2.50 |
| PROFIT | ||||||||
| PBT | 13.40-76.7% | 57.60+442.9% | -16.80-118.1% | 92.70-34.9% | 142.40+152.8% | -269.80-2329.8% | 12.10+104.6% | -265.90 |
| Net Profit | 6.80-86.7% | 51.20+526.7% | -12.00-117.6% | 68.00-40.8% | 114.80+140.6% | -283.10-3245.6% | 9.00+103.4% | -263.40 |
| KEY METRICS | ||||||||
| OPM % | 6.73%-26.38pp | 33.10%+31.97pp | 1.14%-21.32pp | 22.46%+0.50pp | 21.95%+101.85pp | -79.90%-93.15pp | 13.25%+102.75pp | -89.50% |
| NPM % | 4.36%-17.80pp | 22.16%+30.67pp | -8.52%-39.12pp | 30.60%-8.47pp | 39.07%+139.07pp | -100.00%-102.99pp | 3.00%+100.37pp | -97.38% |
| EPS | 0.13-86.5% | 0.96+536.4% | -0.22-117.6% | 1.25-42.1% | 2.16+140.1% | -5.38-3264.7% | 0.17+103.3% | -5.08 |
Corporate Events
Board MeetingEBS
20265Aug
Board Meeting
Emergent BioSolutions announced Q2 2026 financial results, a…
SEC Filing ↗